BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 20860495)

  • 21. Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities.
    Estañ MC; Calviño E; Calvo S; Guillén-Guío B; Boyano-Adánez Mdel C; de Blas E; Rial E; Aller P
    PLoS One; 2014; 9(12):e115250. PubMed ID: 25506699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential.
    Contreras-Lopez R; Elizondo-Vega R; Luque-Campos N; Torres MJ; Pradenas C; Tejedor G; Paredes-Martínez MJ; Vega-Letter AM; Campos-Mora M; Rigual-Gonzalez Y; Oyarce K; Salgado M; Jorgensen C; Khoury M; Garcia-Robles MLÁ; Altamirano C; Djouad F; Luz-Crawford P
    Theranostics; 2021; 11(1):445-460. PubMed ID: 33391485
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
    Issaq SH; Teicher BA; Monks A
    Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic activity of high dose ascorbic acid is enhanced by 2-deoxy-d-glucose in glycolytic melanoma cells.
    Hill-Mündel K; Nohr D
    Biochem Biophys Res Commun; 2021 Mar; 546():90-96. PubMed ID: 33578294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms.
    Laussel C; Léon S
    Biochem Pharmacol; 2020 Dec; 182():114213. PubMed ID: 32890467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
    Ju R; Guo L; Li J; Zhu L; Yu X; Chen C; Chen W; Ye C; Zhang D
    Cancer Lett; 2016 Jan; 370(2):232-41. PubMed ID: 26522259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria.
    Suchorolski MT; Paulson TG; Sanchez CA; Hockenbery D; Reid BJ
    PLoS One; 2013; 8(2):e56884. PubMed ID: 23460817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS; Adhikari JS; Jain V
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure.
    Khaitan D; Chandna S; Dwarakanath SB
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary 2-deoxy-D-glucose impairs tumour growth and metastasis by inhibiting angiogenesis.
    Singh S; Pandey S; Chawla AS; Bhatt AN; Roy BG; Saluja D; Dwarakanath BS
    Eur J Cancer; 2019 Dec; 123():11-24. PubMed ID: 31670076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic state of glioma stem cells and nontumorigenic cells.
    Vlashi E; Lagadec C; Vergnes L; Matsutani T; Masui K; Poulou M; Popescu R; Della Donna L; Evers P; Dekmezian C; Reue K; Christofk H; Mischel PS; Pajonk F
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16062-7. PubMed ID: 21900605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessment of FDG uptake in tumor cells: high FDG uptake as a reflection of oxygen-independent glycolysis dominant energy production.
    Waki A; Fujibayashi Y; Yonekura Y; Sadato N; Ishii Y; Yokoyama A
    Nucl Med Biol; 1997 Oct; 24(7):665-70. PubMed ID: 9352538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation.
    Wang F; Zhang S; Vuckovic I; Jeon R; Lerman A; Folmes CD; Dzeja PP; Herrmann J
    Cell Metab; 2018 Sep; 28(3):463-475.e4. PubMed ID: 30184486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose deprivation produces a prolonged increase in sensitivity to glutamate in cultured rat cortical neurons.
    Vergun O; Han YY; Reynolds IJ
    Exp Neurol; 2003 Oct; 183(2):682-94. PubMed ID: 14552910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Deoxy-D-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways.
    Estañ MC; Calviño E; de Blas E; Boyano-Adánez Mdel C; Mena ML; Gómez-Gómez M; Rial E; Aller P
    Biochem Pharmacol; 2012 Dec; 84(12):1604-16. PubMed ID: 23041229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
    Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
    Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities.
    de Blas E; Estañ MC; Del Carmen Gómez de Frutos M; Ramos J; Del Carmen Boyano-Adánez M; Aller P
    Cancer Cell Int; 2016; 16(1):70. PubMed ID: 27610044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
    Lampidis TJ; Kurtoglu M; Maher JC; Liu H; Krishan A; Sheft V; Szymanski S; Fokt I; Rudnicki WR; Ginalski K; Lesyng B; Priebe W
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):725-34. PubMed ID: 16555088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status.
    Vibhuti A; Muralidhar K; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(4):686-92. PubMed ID: 24518718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.